Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Luciano A. Sposato clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Canada register with Luciano A. Sposato as lead sponsor. Synced 12 Nov 2026
5Current trials
2Recruiting now
0Drugs in these trials
1Trial register
At a glance

Luciano A. Sposato is the lead sponsor of 5 current clinical trials in our Canada register. 2 are recruiting patients now. The most common phase is Observational. The most-studied condition is Stroke.

ClinicalTrials.gov trials by status

  • Recruiting240%
  • Not yet open120%
  • Active, closed240%

Trials by phase

  • Observational360%
  • Not applicable240%
01

Clinical trials sponsored by Luciano A. Sposato

5 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
B2AD-Risk AFDAS Evolution of Burden of AF
NCT06589700 · ClinicalTrials.gov ↗ · Stroke, Atrial Fibrillation
Not applicable Recruiting 2025-10 Canada
MR Evidence of Cardiac Inflammation Post-Stroke
NCT05714618 · ClinicalTrials.gov ↗ · Stroke, Ischemic, Inflammation, Myocardial Injury
Observational Recruiting 2021-10 Canada
WSO BEAT STROKE Initiative
NCT06606054 · ClinicalTrials.gov ↗ · Stroke, PFO - Patent Foramen Ovale, Atrial Fibrillation (AF)
Not applicable Not yet open 2027-03 Canada
Differences in ECG- vs. proLonged cardIac MonItor-DeTected Atrial Fibrillation in STROKE Patients (DELIMIT AF-STROKE)
NCT05822791 · ClinicalTrials.gov ↗ · Stroke, Atrial Fibrillation, TIA
Observational Active, closed 2023-05 Canada
International Multicenter Patent foRamen OVale & strokE (IMPROVE) Registry
NCT04738071 · ClinicalTrials.gov ↗ · Stroke, Patent Foramen Ovale, Atrial Fibrillation
Observational Active, closed 2019-11 Canada

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Luciano A. Sposato trials

10 conditions
Stroke4Atrial Fibrillation3PFO - Patent Foramen Ovale1Atrial Fibrillation (AF)1TIA1Stroke, Ischemic1Inflammation1Myocardial Injury1Patent Foramen Ovale1Atrial Flutter1
05

Questions about Luciano A. Sposato trials

How many clinical trials does Luciano A. Sposato sponsor?

Luciano A. Sposato is the lead sponsor of 5 current trials on ClinicalTrials.gov in our Canada register, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are Luciano A. Sposato trials recruiting?

Yes. 2 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.